Clover Biopharmaceuticals Ltd.'s total assets for Q4 2024 were ¥812.74M, a decrease of -54.78% from the previous quarter. HK:2197 total liabilities were ¥2.45B for the fiscal quarter, a -6.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.